Renal news roundup from AKF

Pain coping skills training (PCST) emerged as a promising nonpharmacologic alternative for managing chronic pain in hemodialysis patients, according to a study ...

Roivios has received Food and Drug Administration (FDA) investigational device exemption approval to conduct a pivotal trial of its JuxtaFlow renal assist devic...

Intensive blood pressure control offers cardiovascular benefits for patients with chronic kidney disease (CKD) comparable to findings from the Systolic Blood Pr...

A study in Open Forum Infectious Diseases shows that Paxlovid is associated with less risk of hospitalization, major adverse cardiovascular events and death in ...

The FDA has declined to approve the expanded use of sotagliflozin as an add-on therapy to insulin for people with type 1 diabetes and CKD, citing an unfavorable...

An observational study suggests that dialysis patients using denosumab have a 45% lower risk of fractures compared with those using oral bisphosphonates but fac...

Children are increasingly affected by kidney stones, a condition traditionally seen in adults, with experts citing diet, genetics and climate change as contribu...

A study in the Journal of the American Geriatrics Society found that multimorbidity is linked to accelerated kidney function decline in older adults. The analys...

A study in JAMA Network Open shows that COVID-19 survivors experience a more significant decline in kidney function than those who recover from pneumonia, parti...